Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2100071	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-11-18	view
JYSB2100070	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2021-03-11	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-11-18	view
JXSS2000067	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-25	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-08-31	view
JXSS2000066	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-25	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-08-31	view
JXSS1900069	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-12-26	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-07-05	view
JXSS1900070	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2019-12-26	百时美施贵宝（中国）投资有限公司	BRISTOL-MYERS Squibb (CHINA) Co Ltd	Certificate Issued	2021-07-05	view
CXSL2100075	LY01015注射液	nivolumab	Injection	Biological Products(3.3)	New Drug Application	2021-02-27	山东博安生物技术有限公司	Shandong BoAn Biotechnology Co Ltd	In Review	2021-02-26	view
CXSL2100076	LY01015注射液	nivolumab	Injection	Biological Products(3.3)	New Drug Application	2021-02-27	山东博安生物技术有限公司	Shandong BoAn Biotechnology Co Ltd	In Review	2021-02-26	view
JXSB2100006	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Supplementary Application	2021-01-08			In Review	2021-01-07	view
JYSB2000104	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-04-09			Certificate Issued	2020-12-30	view
JYSB2000103	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-04-09			Certificate Issued	2020-12-30	view
JXSS2000053	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-03			In Review	2020-12-02	view
JXSS2000054	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2020-12-03			In Review	2020-12-02	view
JXSB2000017	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-09-19			In Review	2020-09-18	view
JXSL2000151	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2020-09-14		Bristol-Myers Squibb Company	In Review	2020-09-11	view
JYSB2000327	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04			Certificate Issued	2020-08-11	view
JYSB2000328	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04			Certificate Issued	2020-08-11	view
JYSB2000330	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04			Certificate Issued	2020-08-07	view
JYSB2000329	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2020-07-04			Certificate Issued	2020-08-07	view
JXSL2000110	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Import Drug Application	2020-07-04		Bristol-Myers Squibb Company	In Review	2020-07-03	view